Xarelto Lawsuit Plaintiffs From Nebraska Allege Drug Caused Serious And Permanent Damage

April 07, 2016 – – BloodThinnerHelp.com reports on yet another lawsuit which was filed against Janssen Pharmaceuticals (a subdivision of Johnson & Johnson corporation) in reference to their new-generation, blood-thinning drug, Xarelto. The plaintiffs filing are a couple from Nebraska who allege that the defendant has manufactured an unsafe anticoagulant drug which will cause the husband to suffer from serious and lasting health complications following a sudden and dangerous bleeding episode. They claim that the health complications have shortened the husband’s life expectancy.

The lawsuit was filed in Eastern Louisiana under case number 2:15-cv-06514, and documents indicate that the husband was prescribed Xarelto in May of 2013. He claims that he took the drug through December of 2013, but stopped using it after he suffered from a dangerous and severe gastrointestinal bleeding episode.

These plaintiffs are not alone in their arguments, unfortunately. Since its 2011 approval by the U.S. Food and Drug Administration, Xarelto has been given two “black box” warnings from the agency. These are the most severe warnings a product can be given before it is fully removed from the market for public sale. In addition, the drug has been the subject of more than 3,400 lawsuits within just 5 years. Plaintiffs filing these lawsuits similarly allege that use of the anticoagulant places those taking it at heightened risk for dangerous bleeding episodes.

Xarelto lawsuits filed in federal courts from across the nation have been transferred and consolidated by the U.S. Judicial Panel on Multidistrict Litigation to form MDL number 2592 in a single Court in Eastern Louisiana. The MDL cases currently number more than 2,800. Additionally, over 600 other Xarelto lawsuits have been consolidated by the Court of Common Pleas in Philadelphia, Pennsylvania to form a mass tort program there.

These Nebraska plaintiffs are requesting compensatory and punitive damages as well as coverage of legal fees. As they await their trial date along with many others, Attorney Joseph Osborne is working to help ensure that others who believe they suffered from health problems after using Xarelto will be given the critical opportunity to explore their legal rights in the matter. Affected patients could be entitled to substantial compensation. To help those wishing to further explore their rights, Attorney Osborne is providing free legal consultations for qualified individuals at this time.

To request additional Xarelto lawsuit information, or to ask questions, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60009148